Humanin vs Glutathione (GSH)
Both Humanin and Glutathione (GSH) are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.
Humanin
Evidence BHumanin (HN)
A 24-amino-acid mitochondrial-derived peptide with cytoprotective effects across Alzheimer's, diabetes, and atherosclerosis preclinical models. Endogenous levels decline sharply with age.
View full Humanin profile →Glutathione (GSH)
Evidence BReduced L-Glutathione
Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.
View full Glutathione (GSH) profile →Side-by-Side
| Attribute | Humanin | Glutathione (GSH) |
|---|---|---|
| Evidence Grade | B | B |
| FDA Status | Not FDA-approved — mitochondrial-derived peptide research compound | Not FDA-approved as therapeutic — sold as supplement; intravenous use compounded |
| Typical Dose | Research range: 0.5–1 mg subcutaneous (rare clinical use) | 200–600 mg sublingual / 600–2400 mg IV (compounded) |
| Clinics Indexed | 5 | 312 |
| Categories | mitochondrial, longevity, neuroprotection | antioxidant, longevity |
Key reported benefits — Humanin
- ✓Cytoprotection
- ✓Anti-amyloid effects
- ✓Insulin sensitization
Key reported benefits — Glutathione (GSH)
- ✓Master antioxidant
- ✓Liver detoxification support
- ✓Oxidative stress reduction
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.